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Abstract
Background: Pichia pastoris has been recognized as an effective host for recombinant protein production. A number 
of studies have been reported for improving this expression system. However, its physiology and cellular metabolism 
still remained largely uncharacterized. Thus, it is highly desirable to establish a systems biotechnological framework, in 
which a comprehensive in silico model of P. pastoris can be employed together with high throughput experimental 
data analysis, for better understanding of the methylotrophic yeast's metabolism.
Results: A fully compartmentalized metabolic model of P. pastoris (iPP668), composed of 1,361 reactions and 1,177 
metabolites, was reconstructed based on its genome annotation and biochemical information. The constraints-based 
flux analysis was then used to predict achievable growth rate which is consistent with the cellular phenotype of P. 
pastoris observed during chemostat experiments. Subsequent in silico analysis further explored the effect of various 
carbon sources on cell growth, revealing sorbitol as a promising candidate for culturing recombinant P. pastoris strains 
producing heterologous proteins. Interestingly, methanol consumption yields a high regeneration rate of reducing 
equivalents which is substantial for the synthesis of valuable pharmaceutical precursors. Hence, as a case study, we 
examined the applicability of P. pastoris system to whole-cell biotransformation and also identified relevant metabolic 
engineering targets that have been experimentally verified.
Conclusion: The genome-scale metabolic model characterizes the cellular physiology of P. pastoris, thus allowing us to 
gain valuable insights into the metabolism of methylotrophic yeast and devise possible strategies for strain 
improvement through in silico simulations. This computational approach, combined with synthetic biology techniques, 
potentially forms a basis for rational analysis and design of P. pastoris metabolic network to enhance humanized 
glycoprotein production.
Background
In the biopharmaceutical industry, over 70% of the thera-
peutic proteins under preclinical and clinical develop-
ment are glycosylated and there has been an increasing
need for highly efficient glycoprotein expression systems.
Mammalian systems such as Chinese hamster ovary
(CHO) cells have been most widely used since they have
been extensively characterized and are capable of human-
like glycosylation. However, they typically exhibit low
survivability and low recombinant protein productivity
unless sophisticated experimental techniques were
employed [1]. On the other hand, although yeast systems
typically produce hyper-mannosylated proteins with poor
bioactivity in humans, recent advances in yeast glycoen-
gineering, especially for Pichia pastoris, enabled the syn-
thesis of humanized glycoproteins with substantially
improved bioactivity [2,3]. Furthermore, since the scale-
up of production in yeast is a well-established technology,
we can potentially achieve cost-effective and high-
throughput production of therapeutic glycoproteins [2,3].
Thus, the methylotrophic yeast P. pastoris is expected to
be one of the promising hosts for industrial production of
recombinant protein in the near future. Indeed, compa-
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nies are already beginning to use P. pastoris for the pro-
duction of several therapeutic proteins [4,5].
A number of studies have been carried out for under-
standing and enhancing physiological properties of P.
pastoris. These studies have elucidated various favorable
characteristics of the organism, which makes it more
attractive for large-scale production of recombinant
humanized glycoprotein [6-10]. In particular, the lower
tendency of hyper-mannosylation of proteins and nega-
tive Crabtree phenotype can present P. pastoris as a more
superior expression host than the well-characterized Sac-
charomyces cerevisiae [7,11]. Hence, it is highly desirable
to make significant efforts for improving the P. pastoris
strain in order to achieve economic feasibility and effi-
ciency [12-14]. In this regard, the emerging paradigm of
systems biotechnology can play an important role in
identifying key targets for strain improvement [15].
Systems biotechnology integrates high-throughput
omics data and in silico modeling and analysis to under-
stand and design cellular system to achieve desirable
properties [16]. This approach has been successfully
applied to one of the best-characterized expression sys-
tem, S. cerevisiae, which was metabolically engineered for
improved production of chemicals and biopharmaceuti-
cals [17,18]. For example, targets for genetic manipula-
tion have been identified to enhance the production of
bioethanol [19,20] and human superoxide dismutase [21].
Therefore, we can yield similar benefits for P. pastoris by
resorting to the systems biotechnological approach,
which requires a comprehensive in silico metabolic model
[22].
To date, more than 50 genome-scale metabolic models
have been reconstructed for over 30 species from three
main domains of life, i.e. Archaea, Bacteria and Eukarya
[23,24]. Various applications of genome-scale metabolic
models have been reported for characterizing cellular
metabolism and guiding metabolic engineering. Exam-
ples include characterization of various organisms rang-
ing from unicellular bacteria such as Escherichia coli [25]
and Zymomonas mobilis (Widiastuti H, Kim JY, Selvarasu
S, Karimi IA, Kim H, Seo JS, Lee DY: Genome-scale mod-
eling and in silico analysis of ethanologenic bacteria
Zymomonas mobilis, submitted) to complex mammalian
systems such as Mus musculus [26] and even Homo sapi-
ens [27]; phenotypic prediction of metabolic-gene dele-
tion strains of E. coli [28]; and identification of metabolic
engineering targets to enhance biochemical production
capability of E. coli [29,30]. Towards this end, we recon-
structed a genome-scale model of P. pastoris metabolism
which allows us to elucidate interesting features of the
methylotrophic yeast and identify engineering targets for
achieving enhanced physiological properties of the strain.
Results
Characteristics of reconstructed metabolic network
Following the procedure illustrated in Figure 1, a
genome-scale network of P. pastoris metabolism was
reconstructed (see Methods). During the reconstruction
process, significant efforts were required in the gap-filling
process. Essential metabolic reactions are added sequen-
tially to the draft model, through repeated cell growth
simulations using constraints-based flux analysis, to
ensure  in silico viability. For example, a metabolic gap
exists in the initial draft of the methonine biosynthetic
pathway as the gene coding for the enzyme catalyzing
transamination of 2-keto-4-methylbutyrate to form
methionine [31] was not found and had to be added man-
ually. Similarly, in order to allow mitochondrial localiza-
tion of acyl-carrier protein for fatty acid synthesis, a
mitochondrial transport reaction was introduced to the
model, thus improving metabolic network connectivity.
The reconstructed metabolic model of P. pastoris,
iPP668, accounts for 668 metabolic genes, 1,361 reactions
and 1,177 metabolites segregated into 8 compartments:
cytosol, endoplasmic reticulum, extracellular matrix,
Golgi apparatus, mitochondria, nucleus, peroxisome and
vacuole as summarized in Table 1 (see Additional file 1
for model details). The metabolic reactions include 904
intra-compartment reactions, 308 inter-compartment
reactions, and 149 extracellular exchange reactions.
These metabolic reactions are also classified into 62 sub-
systems (Table 2) which include pathways in central car-
bon metabolism, amino acid, carbohydrate and lipid
biosynthetic pathways, and more notably, the methanol
utilization pathway previously characterized by [32]. In
the fully compartmentalized model, metabolites localized
in different cellular compartments (e.g. cytosolic pyru-
vate, pyr[c] and mitochondrial pyruvate, pyr[m]) are con-
sidered as distinct metabolites. Thus, without
considering sub-cellular compartmentalization, this
model accounts for 681 unique metabolites.
In iPP668, we have included a biomass equation which
is composed of biosynthetic precursors and energy
requirement. Appropriate coefficients of amino acids and
carbohydrates were obtained from a recent experimental
composition analysis of P. pastoris [33] while lipid and
sterol compositions were evaluated based on an analyti-
cal study of the cellular membranes [34]. The reported
G+C content of 41.1% [35] forms the basis of our calcula-
tion of nucleotide composition and the composition of
the individual RNA is assumed to be similar to that of S.
cerevisiae [36] according to findings by [33]. We also cal-
culated the growth associated ATP requirement for the
polymerization of proteins, DNA and RNA and included
this energy requirement as a part of the biomass synthesis
equation (see Additional file 2 for details).Chung et al. Microbial Cell Factories 2010, 9:50
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Unique and conserved features in P. pastoris metabo-
lism were further elucidated by comparing iPP668 with
two model organisms: S. cerevisiae (iMM904) [37] and E.
coli (iAF1260) [25]. It should be noticed that we disre-
garded the sub-cellular compartmentalization of reac-
tions for the comparative analysis of metabolic capability
by eliminating inter-compartmental transport and meta-
bolic reaction duplicates in different compartments.
From this comparison, there are 292 reactions and 439
metabolites that are common to the three species (Figure
2). These reactions largely belong to the central carbon
metabolism and amino acid biosynthetic pathways. The
415 reactions and 196 metabolites, shared only by P. pas-
toris and S. cerevisiae, are generally classified under the
lipid and carbohydrate biosynthetic pathways while the
79 reactions and 46 metabolites unique to P. pastoris are
mainly from the methanol utilization pathway (Figure 3)
and certain parts of lipid metabolism which are yeast-
Figure 1 Reconstruction of Pichia pastoris. A recently published genome of P. pastoris [35] and various online databases, including KEGG [71], Meta-
Cyc [70], PubMed http://www.ncbi.nlm.nih.gov/pubmed/, BRENDA [68] and ExPASy ENZYME database [69], were used to reconstruct and manually 
curate the iPP668 metabolic model.Chung et al. Microbial Cell Factories 2010, 9:50
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specific. It is further observed that the lipid biosynthetic
pathways of both yeasts are structurally identical, only
differing in the composition of fatty acid chains.
Validation of phenotypic predictions
In this study, we validated the iPP668 metabolic model by
checking the difference between predicted cellular phe-
notypes and experimental observations obtained from
two sets of chemostat culture conditions, glucose mini-
mal medium (see Methods) and glycerol/methanol mixed
medium [38]. In both cases, we maximized cell growth
while constraining carbon source uptake rates at experi-
mentally determined levels.
In the case of glucose minimal medium, we observed
that the predicted cell growth, oxygen uptake and carbon
dioxide evolution rates are highly consistent with the data
obtained from our chemostat experiments (Figure 4).
Discrepancies between experimental observations and
model predictions are within 20% which can be consid-
ered acceptable. The constantly higher growth and gas-
eo us  e x c h a n g e  r a t e  p r ed i c t i o n s  ca n  be  d u e  t o  pos s i b l e
errors in biomass composition data obtained from vari-
ous sources (see Methods and Additional file 2). It should
be noted that in order to mimic physiological states, we
specified conditional parameters (see Methods). NGAM
requirement (2.3 mmol ATP/gDCW-hr) was estimated
from our chemostat data whereas we defined P/O ratio
(1.48 mol ATP/mol O) based on previous studies [39,40].
Another set of chemostat culture data [38] also allowed
us to evaluate the fidelity of physiological predictions
under the glycerol/methanol mixed media condition. In
this case, the NGAM requirement is estimated to be
about 6 mmol ATP/gDCW-hr while the P/O ratio
remains unchanged. Predictions for cell growth in glyc-
erol minimal media are reasonably consistent with exper-
imental observations but the discrepancy becomes
significant when methanol uptake rate is high (Table 3).
In the latter case, methanol uptake induces the synthesis
Table 1: Summary statistics of metabolic reconstruction for two yeast models
Genome characteristics P. pastoris S. cerevisiae
Genome length 9.3 Mbp 12.1 Mbp
G+C content 41.1% 38.3%
Coding genes 5,313 6,607
Model characteristics
No. of genes 668 904
No. of gene-associated 
reactions
1,007 1,043
No. of other reactions 354 534
No. of internal reactions 1,212 1,413
No. of exchange reactions 149 164
No. of metabolites 1,177 1,228
Compartment No. of metabolites No. of reactions No. of metabolites No. of reactions
Cytosol 607 623 634 709
E n d o p l a s m i c  r e t i c u l u m 2 81 52 81 5
Extracellular matrix 149 12 164 14
Golgi apparatus 15 4 17 6
Mitochondria 235 163 241 175
N u c l e u s 3 51 64 01 6
Peroxisome 84 66 80 65
Vacuole 24 3 24 3
Inter-compartment - 452 - 574
Total 1,177 1,361 1,228 1,577
Data of S. cerevisiae is obtained from [37] and Saccharomyces Genome Database http://www.yeastgenome.org/.Chung et al. Microbial Cell Factories 2010, 9:50
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Table 2: Functional classification of metabolic reactions
Alanine and Aspartate Metabolism 9 Other Amino Acid Metabolism 10
Alternate Carbon Metabolism 21 Oxidative Phosphorylation 18
Anaplerotic reactions 10 Pantothenate and CoA Biosynthesis 16
Arabinose Metabolism 3 Pentose Phosphate Pathway 13
Arginine and Proline Metabolism 31 Phospholipid Biosynthesis 42
Asparagine metabolism 2 Phospholipid Metabolism 8
ATP maintenance 1 Porphyrin and Chlorophyll Metabolism 13
Biomass requirement 1 Purine and Pyrimidine Biosynthesis 51
Citric Acid Cycle 13 Pyridoxine Metabolism 8
Complex Alcohol Metabolism 22 Pyruvate Metabolism 17
Cysteine Metabolism 7 Quinone Biosynthesis 17
Fatty Acid Biosynthesis 61 Riboflavin Metabolism 11
Fatty Acid Degradation 42 Sphingolipid Metabolism 57
Fatty Acid Metabolism 3 Starch and Sucrose Metabolism 2
Folate Metabolism 23 Sterol Metabolism 48
Fructose and Mannose Metabolism 8 Taurine Metabolism 1
Galactose metabolism 2 Thiamine Metabolism 12
Glutamate metabolism 15 Threonine and Lysine Metabolism 16
Glutamine Metabolism 3 Transport, Endoplasmic Reticular 8
Glycerolipid Metabolism 11 Transport, Extracellular 145
Glycine and Serine Metabolism 19 Transport, Golgi Apparatus 2
Glycolysis/Gluconeogenesis 22 Transport, Mitochondrial 91
Glycoprotein Metabolism 5 Transport, Nuclear 5
Histidine Metabolism 14 Transport, Peroxisomal 20
Methanol Metabolism 7 Transport, Vacuolar 25
Methionine Metabolism 18 tRNA charging 35
NAD Biosynthesis 18 Tyrosine, Tryptophan, and Phenylalanine Metabolism 34
Nitrogen Metabolism 3 Valine, Leucine, and Isoleucine Metabolism 19
Nucleotide Salvage Pathway 61 Xylose Metabolism 2
Other 11 Exchange reactions 149
Total 1361
The table shows the number of reactions classified under each subsystem.
of alcohol oxidase enzyme and generation of peroxisome
lipid membrane which may cause substantial alteration in
the cellular composition of amino acids and lipids [7,41].
Moreover, the effects of metabolic regulation, such as the
repression of AOX by glycerol [42], that are not captured
in the current model may also contribute to the discrep-
ancy. Thus, future works in the experimental analysis of
changes in biomass composition during methanol induc-
tion can provide necessary information to improve pre-
diction capability of the current metabolic model.
Carbon sources for recombinant protein production
Among the various carbon sources available, methanol is
the inducer for AOX promoter which is commonly used
for heterologous protein production in P. pastoris. How-
ever, the yeast typically grows very slowly on this carbon
source [7]. Thus, an alternative substrate can be supplied
during the initial phase to achieve high cell density, fol-
lowed by shifting into methanol induction phase for pro-
tein production [43]. Based on this feeding strategy,
desirable carbon sources must be able to yield high
growth rate with high capacity to synthesize amino acids
in the earlier phase so that available amino acid pools can
be diverted to produce recombinant protein in the later
phase. In this sense, we can explore the effect of various
carbon sources (alanine, glucose, glycerol, methanol, sor-
bitol and trehalose) on cellular metabolism of P. pastoris
using the reconstructed model and as such, identify theChung et al. Microbial Cell Factories 2010, 9:50
http://www.microbialcellfactories.com/content/9/1/50
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Figure 2 Comparison of metabolic model reconstructions. The P. pastoris metabolic model reconstruction iPP668 is being compared with S. cer-
evisiae [37] and E. coli [25] and it is found that there is no reaction that is shared by E. coli and P. pastoris. The number in each section of the Venn diagram 
indicates the number of reactions that are common or specific to the respective organism(s).
Figure 3 Methanol utilization pathway. Reactions unique to P. pastoris are highlighted in blue. Metabolites such as water, protons, phosphate are 
omitted (see Additional file 1 for abbreviation and reaction details).Chung et al. Microbial Cell Factories 2010, 9:50
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best candidate for recombinant protein production. To
do so, we simulated cell growth by constraining the sup-
ply of each carbon source to one C-mmol/gDCW-hr (i.e.
0.167 mmol/gDCW-hr for glucose, 0.333 mmol/gDCW-
hr for glycerol, 1 mmol/gDCW-hr for methanol, etc.).
Based on the first criterion of high growth yield, glyc-
erol is the most promising candidate for recombinant
protein production, followed by sorbitol (Figure 5). Gen-
erally, high utilization of the central metabolism can lead
to increased production of various precursors, which can
further synthesize building blocks required for the bio-
mass. However, the resulting flux distributions indicated
that the utilization of central carbon metabolism is the
highest for methanol uptake despite yielding the lowest
growth rate. We can understand this observation by
examining gaseous exchange rates and ATP flux-sum for
methanol utilization. The significantly higher turnover
rate of ATP and gaseous exchange rates suggest that
much of the resources have been diverted to energy gen-
eration during methanol utilization. The low respiratory
quotient resulting from this diversion of resources is con-
sistent with findings from several experimental studies
Figure 4 Chemostat culture simulation results. Data points for each chemostat experimental data point were generated by constraints-based flux 
analysis implemented with glucose uptake rate constrained at the respective experimentally determined values.Chung et al. Microbial Cell Factories 2010, 9:50
http://www.microbialcellfactories.com/content/9/1/50
Page 8 of 15
[38,44]. Hence, the higher utilization of central metabo-
lism is a consequence of the high energy requirement of
methanol metabolism in P. pastors.
Not surprisingly, flux-sum distribution profiles on vari-
ous carbon sources confirmed that sorbitol and glycerol
are capable of generating higher amino acid flux-sum
compared to others. Thus, this large pool of amino acids
can potentially be diverted to synthesize recombinant
protein during the induction phase, indicating sorbitol
and glycerol are desirable carbon sources for recombi-
nant protein production in terms of both growth yield
and amino acid biosynthetic capability (Figure 5). How-
ever, if AOX  promoter is used for recombinant protein
expression, sorbitol will be more superior as glycerol is
known to repress the promoter [42]. Therefore, the cur-
rent model-driven evaluation of various carbon sources
recommends a feeding strategy of supplying sorbitol as
the co-substrate during methanol induction phase to pro-
vide the necessary resources for recombinant protein
production.
Application of P. pastoris for whole-cell biotransformation
Apart from recombinant protein production through
methanol induction, we managed to identify another
potential application of culturing P. pastoris in methanol.
From the in silico analysis, it was observed that growing P.
pastoris  in methanol minimal media can exhibit high
turnover of NADH, implying the potential capability of P.
pastoris for whole-cell biotransformation. For example,
value-added chemical precursors, e.g. 2,3-butanediol, can
be synthesized via enzymatic reduction of ketones, e.g.
acetoin, which requires NADH or NADPH regeneration
[45-49]. In this aspect, the high rate of NADH regenera-
tion in P. pastoris is suitable for biocatalysis of butanediol
dehydrogenase reaction to convert acetoin into 2,3-
butanediol [50]. To achieve cost-effectiveness, we can fur-
ther enhance the NADH regeneration of P. pastoris by
identifying gene targets to be overexpressed through the
modified flux analysis implementation (see Methods).
Simulation results show that when P. pastoris is sup-
plied with 1 mmol/gDCW-hr of acetoin, attenuating the
flux activity of some reactions can give rise to a propor-
tional decrease in the maximum achievable butanediol
dehydrogenase reaction flux (Figure 6). Fixing the fluxes
of these reactions imposes an upper limit on the flux of
butanediol dehydrogenase. Thus, such reactions are
"directionally coupled" to 2,3-butanediol production,
according to [51]. For the in vivo system, the directionally
coupled reactions will become bottlenecks only if the cor-
responding enzymes were not expressed adequately while
the maximum rate of 2,3-butanediol production may be
achievable upon the expression of the enzymes at high
levels. From this inference, the list of target enzymes
identified can be genetically enhanced for relieving the
bottleneck if the experimentally observed 2,3-butanediol
production is significantly less than the theoretical value.
Discussion
The genome-scale metabolic modeling and analysis pro-
cedure presented in this study can potentially be used to
design culture media for enhancing the performance of P.
pastoris. We have shown through the analysis of carbon
source utilization that glycerol and sorbitol are the best
candidates for achieving high growth yields in P. pastoris
cell culture (Figure 5). Furthermore, with regards to
recombinant protein production using the AOX  pro-
moter, sorbitol is clearly better than glycerol since the lat-
ter represses the AOX promoter [42]. The generation of
Table 3: In silico prediction of growth in glycerol/methanol mixtures
Dilution rate, D
D = 0.16 D = 0.16 D = 0.05 D = 0.05
Exp a Pred Exp a Pred Exp a Pred Exp a Pred
Cell growth 0.16 0.18 0.16 0.19 0.05 0.05 0.05 0.05
Glycerol uptake b 2.75 2.23 1.09 0.57
Methanol uptake b - 2.73 - 2.33
CO2 evolution 2.35 2.40 3.60 3.22 1.56 1.72 2.21 2.37
O2 uptake 3.62 3.56 7.20 5.47 2.16 2.20 4.85 3.76
Respiratory quotient 0.65 0.68 0.50 0.59 0.72 0.78 0.46 0.63
P/O ratio - 1.48 - 1.48 - 1.47 - 1.49
In the chemostat culture, growth rate is equivalent to dilution rate. Units of measurements are given as follows: growth/dilution rate, 1/hr; 
carbon source uptake or gaseous exchange rates, mmol/gDCW-hr; Respiratory quotient, mol CO2/mol O2; P/O ratio, mol ATP/mol O.
a Data from [38].
b Carbon source uptake rates are model input parameters which are not predicted.Chung et al. Microbial Cell Factories 2010, 9:50
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high flux-sum for many of the amino acids due to sorbitol
utilization (Figure 5) can provide a possible explanation
for the successful use of sorbitol in recombinant protein
expression experiments which utilizes methanol induc-
tion [52-55]. Although the technique of expressing
recombinant protein using the AOX promoter has been
successful, alternative promoters, such as gylceraldehyde
3-phosphate dehydrogenase (GAP), glutathione-depen-
dent formaldehyde dehydrogenase (FLD1), peroxisomal
matrix protein (PEX8) and secretion GTPase (YPT1) pro-
moters, have been proposed since methanol, a petroleum
compound, may not be perceived as an appropriate raw
material for production of proteins for human consump-
tion [56]. For the utilization of these alternative promot-
ers, sorbitol may not be the best candidate due to
regulatory factors and further analysis using iPP668 can
provide us with the corresponding best carbon source
selection.
Another application of iPP668 is the rational identifica-
tion of metabolic engineering targets. From our analysis
of carbon source utilization, we found that growing P.
pastoris in methanol minimal medium is suitable for bio-
catalysis of ketone reduction such as the conversion of
acetoin into 2,3-butanediol, which requires NADH
regeneration [50]. In this case, the key enzyme, butane-
diol dehydrogenase, is overexpressed but the native
metabolism of the host may consist of some limiting reac-
tions or bottlenecks that prevent the maximum utiliza-
tion of the butanediol dehydrogenase reaction. Some of
the bottleneck reactions, AOD, FALD and FDH, identi-
Figure 5 Flux and flux-sum distributions for different carbon sources. Growth rate, flux and flux-sum values were generated based on individual 
carbon source uptake rate of 1 C-mmol/gDCW-hr. The color intensity of the lines in the central carbon metabolic network corresponds to the flux 
values. Precursor metabolites are in blue and the building blocks derived from each of them are specified in the text boxes. The heat-maps on the left 
and right illustrate the flux and flux-sum distributions, respectively. Similarly, the color intensity corresponds to the flux or flux-sum values normalized 
with respect to the maximum for each reaction or metabolite.Chung et al. Microbial Cell Factories 2010, 9:50
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fied by our in silico analysis have been demonstrated to be
appropriate metabolic engineering targets for enhancing
2,3-butanediol production [50] and the other potential
targets, DAK, G3PD1ir, G3PT and GLYCDy, can serve as
hypotheses for future experimental validation. Hence,
using the proposed computational framework, iPP668
can be a useful tool for tackling other metabolic engineer-
ing problems associated with P. pastoris.
Protein glycosylation is an important post-translational
process which can affect the protein's secretion, folding
and bioactivity [57,58]. Thus the extension of iPP668 to
account for glycosylation processes can potentially
increase the utility of the model. The design of glycosyla-
tion pathway through glycoengineering is critical for
recombinant protein production in yeasts [3]. When
combined with synthetic biology, effective glycoengineer-
ing techniques can even produce synthetic glycoproteins
with enhanced therapeutic function [59]. Hence, it is
highly desirable to develop a framework to rationally
design the glycosylation pathway by analyzing the inter-
action between cellular metabolism and post-transla-
tional modification mechanisms, and subsequently
optimizing the production of desired glycoforms, as
shown in previous theoretical studies [60-63]. Although
the limitations of constraints-based flux analysis prohibit
detail modeling of the diverse range of glycoforms, it is
still possible to account for the overall metabolic require-
ment involved in protein glycosylation as discussed by
[26]. We can characterize the glycan structure of any tar-
get glycoprotein and evaluate the stoichiometry of mono-
saccharides required to synthesize it using advanced
glycomics techniques [64]. We can then construct a
lumped glycoprotein synthesis equation that also
describes the energy requirement of glycosidic bond for-
mation [65]. By adding this equation to the existing meta-
bolic model, we can investigate the sensitivity of cellular
metabolism to the carbohydrate and energy requirements
of glycosylation. Consequently, this extended model
offers a good platform for the integration of glycomics
and other omics, such as metabolomics and fluxomics,
for a large-scale systems analysis of the cellular physiol-
ogy in Pichia pastoris.
During the peer review process of the current work, we
identified another independent reconstruction effort that
Figure 6 Effect of flux activity on 2,3-butanediol production. The flux activity level shown on the x-axis refers to the flux activity normalized with 
respect to the maximum flux activity value for each reaction. This value is also equivalent to the factor k used to carry out the analysis (see Methods). 
Reaction abbreviations: AOD, alcohol oxidase; DAK, dihydroxyacetone kinase; FALDH, formaldehyde dehydrogenase; FDH, formate dehydrogenase; 
G3PD1ir, glycerol-3-phosphate dehydrogenase; G3PT, glycerol-3-phosphatase; GLYCDy, glycerol dehydrogenase; SFGTH, S-formylglutathione hydral-
ase (see Additional file 1 for details).Chung et al. Microbial Cell Factories 2010, 9:50
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has been made by Sohn et al. [66], presenting the
genome-scale model of P. pastoris metabolism,
PpaMBEL1254. A model comparison between iPP668
and PpaMBEL1254 shows that both models are fully
compartmentalized into 8 subcellular compartments, and
capable of describing P. pastoris cellular metabolism
under various carbon source uptake conditions. None-
theless, several differences between the current study and
Sohn et al. can be found with respect to the model size,
validation and subsequent analysis. The size of iPP668
(668 genes, 1,361 reactions, 1,177 metabolites) is larger,
providing more information than PpaMBEL1254 (540
genes, 1,254 reactions, 1,147 metabolites). In addition,
iPP668 was validated by two sets of chemostat experi-
mental data while Sohn et al. used batch fermentation
data for qualitative model validation. Interestingly, Sohn
et al. explored the capability of P. pastoris to produce
recombinant proteins such as human serum albumin and
human superoxide dismutase under various oxygenation
rates using PpaMBEL1254, while we have discussed the
general procedure to represent the protein production in
the model based on amino acid biosynthetic rates. How-
ever, the PpaMBEL1254 model did not clearly describe
the methanol utilization pathway of P. pastoris which is
an important metabolic characteristic of great interest for
applications in recombinant protein production and
biotransformation, as discussed in the current study.
Therefore, we suggest the combination of iPP668 and
PpaMBEL1254 for future model expansion and systems
metabolic engineering studies to harness the useful infor-
mation provided by two genome-scale metabolic models.
Conclusion
In this study, we have reconstructed a genome-scale met-
abolic model of the methylotrophic yeast P. pastoris,
which has been developed for recombinant protein pro-
duction as well as whole-cell biotransformation. The met-
abolic model was manually curated with information
from literature and various databases to provide a good
description of cell growth under various culture condi-
tions through the use of constraints-based flux analysis.
Validation of the curated model has shown that the
model was able to reproduce key characteristics of P. pas-
toris metabolism reported in various experimental stud-
ies. The analysis of P. pastoris growth on different
substrates has also allowed us to understand some useful
application of the methylotrophic yeast and to generate
testable hypotheses which can help to improve its bio-
chemical production capability. Future works in the
experimental analysis of P. pastoris can potentially
enhance the predictive capability of the current model
which can be integrated with high-throughput omics
analysis for yeast systems biotechnology.
Methods
Reconstruction of metabolic model
The metabolic network of P. pastoris was reconstructed
based on a recently published genome annotation of the
organism [35]. An initial draft of the network is con-
structed by compiling annotated metabolic genes; rele-
vant reactions are added with the respective gene-
protein-reaction (GPR) assignments [23] based on infor-
mation from online databases such as BioSilico [67],
BRENDA [68], ExPASy ENZYME [69], MetaCyc [70] and
KEGG [71] . The initial draft is subsequently refined
through manual curation and gap-filling processes. In
addition, constraints-based flux analysis was used to
identify missing links that can be filled by adding neces-
sary steps leading to the cell growth. The process of
model refinement typically requires additional informa-
tion from scientific references and publications which
can be found in the PubMed database. Subsequently, rele-
vant experimental validation and model analysis further
refine the model in an iterative manner (Figure 1).
Constraints-based flux analysis
Cellular metabolism can be simulated by constraints-
based flux analysis as described elsewhere [72-74]. We
used this approach to evaluate cell growth of P. pastoris
under various culture conditions. Mathematically, the
rate of biomass synthesis forms the objective function to
be maximized, subjected to stoichiometric, thermody-
namic and reaction capacity constraints, resulting in the
following linear programming problem:
where  Sij  refers to the stoichiometric coefficient of
metabolite i involved in reaction j and vj is the flux of
reaction  j. Reaction capacity and thermodynamic con-
straints, based on reaction reversibility information, are
specified using the parameters αj and  βj indicating the
lower and upper bounds of reaction j, respectively. Unless
experimental measurements are available, we typically
specify βj = inf and αj = -inf (for reversible reactions) or αj
= 0 (for irreversible reactions). In addition, gene deletion
can be simulated by setting αj = βj = 0 for the associated
metabolic reactions. In this study, the linear program-
ming problem was solved using General Algebraic Mod-
eling System (GAMS) Integrated Development
Environment (IDE) version 22.7 [75].
max v
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Stipulation of condition-specific parameters
The values of condition-specific parameters, such as non-
growth associated ATP maintenance requirement
(NGAM) and P/O ratio, vary with culture media and
other environmental conditions. Thus, these values have
to be determined for simulation of different experimental
conditions. NGAM requirement is specified by fixing the
flux value of ATP maintenance reaction. The experimen-
tal value is determined by plotting the uptake rates of car-
bon source against dilution rates from a chemostat run
(see Additional file 2 for calculation details). P/O ratio is
defined as the ratio of ATP produced to oxygen atom
reduced by the respiratory chain. Thus, this value can be
determined by calculating 0.5(vATPS3m/vCYOOm) where
ATPS3m and CYOOm refer to ATP synthase and cyto-
chrome c oxidase reactions in mitochondria compart-
ment, respectively. It can be changed by adjusting
stoichiometric coefficients of hydrogen ions in the cyto-
chrome c oxidase reaction. (See Additional file 1 for reac-
tion details.)
Describing metabolite turnover rate using flux-sum
The metabolic state of a cellular system can be described
by the interconversion of metabolites. Here, the turnover
rate of intermediate metabolites is defined as their flux-
sum [76,77]. Since the overall consumption and genera-
tion rates are equal under the steady-state assumption,
the flux-sum of metabolite i  can be formulated as
. Each |Sijvj| term in this summation series
gives us the absolute rate of consumption/generation of
metabolite i due to reaction j and thus by halving the sum
of these terms, we can obtain the overall turnover rate for
metabolite i.
Identification of gene targets for overexpression
In metabolic engineering, bottlenecks in the metabolic
network can be considered as potential gene targets to be
overexpressed [78]. Therefore, it is important to devise a
systematic framework for identifying such targets. In this
regard, we modified the flux analysis procedure to detect
relevant reactions that can potentially affect the biosyn-
thetic rate of the product of interest (vtarget). In our com-
putational framework, vtarget is maximized under different
levels of reaction flux perturbation. Taking into consider-
ation that the enhancement of biochemical production
typically results in attenuated growth rate, we set the
lower limit of cell growth to 50% of the maximum value
( ). The mathematical formulation can lead to the
following mixed integer linear programming (MIP) prob-
lem:
We define "flux activity" as the absolute value of a reac-
tion flux. Thus   and   refer to the maximum
and minimum flux activity of reaction j  respectively,
under the cell growth constraint of  . In the
above formulation, big M is some arbitrarily chosen large
value representatiing the flux upper limit which we typi-
cally specify as 1000 mmol/gDCW-hr. By solving the MIP
problem for each reaction j and different values of k (in
this case: 0, 0.25, 0.5, 0.75 and 1.0), we can evaluate the
effect of individual reaction flux activity on the flux of
any target reaction. The MIP is implemented and solved
in GAMS IDE version 22.7 [75].
Strain and chemostat culture
A wild type Pichia pastoris X-33 (Invitrogen, Carlsbad,
CA, USA) was used for the chemostat culture. A single
colony of the strain was inoculated into 20 mL of yeast
protein dextrose (YPD) medium containing (per liter): 20
g of glucose, 10 g of yeast extract, and 20 g of Bacto-pep-
tone and incubated overnight at 30°C. The culture was
transferred to a 500 mL Erlenmeyer flask containing 100
mL of YPD broth and incubated overnight at 30°C. This
culture was used as a seed for the chemostat culture using
2.5 L jar fermentors (KoBiotech, Incheon, Korea) with a
constant volume of 800 mL. Cells were first batch-cul-
tured in a defined glucose minimal medium containing
(per liter): 50 g glucose, 1.5 g MgSO4·7H2O, 0.2 mg Biotin,
3 g KH2PO4, 15 g (NH4)2SO4, 2.0 mL of trace salts stock
solution and 1.0 mL of a solution containing 2 g/L biotin
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in 1M NaOH. The trace element solution contained (per
liter) 5 mL H2SO4, 4.0 g CuSO4·5H2O, 14.0 g
MnSO4·H2O, 2.6 g Na2MoO4·2H2O, 4.0 g H3BO3, 4.0 g
CoCl2·6H2O, 22.0 g ZnSO4·7H2O, 55.0 g CaCl2·2H2O and
37.5 g FeCl3·6H2O. Then, the chemostat culture was initi-
ated after the depletion of glucose at the end of batch cul-
ture and continued at different dilution rates under the
same medium condition. The cultures were carried-out
at 30°C and pH 6.0 controlled by 24% NH4OH. Agitation
and aeration were fixed at 800 rpm and 1 vvm, respec-
tively, and the dissolved oxygen in the culture medium
level was maintained above 10% air saturation during the
entire culture period. Cultures were assumed to be in
steady-state after at least 5 volumes changes.
Analytical methods
The concentration of biomass was determined as dry cell
weight (DCW). Culture samples were collected after
achieving steady-state for different dilution rates. The
collected samples were centrifuged and washed twice
with ultrapure water and then the pellet was dried at
100°C. The culture supernatants were used for measuring
the concentration of glucose, organic acids, glycerol and
ethanol by high-pressure liquid chromatography (Gilson,
Middleton, WI, USA) equipped with an HPX 87H col-
umn (Bio-Rad, Hercules, CA, USA), an ERC-7515A RI
detector (ERC, Tokyo, Japan) and a UV detector
(Youngin, Seoul, Korea). Analysis of carbon, nitrogen and
hydrogen content was performed with a CHN analyzer
(Carlo Erba Instruments, Rodano, Italy) of lyophilized
cells as suggested by [79]. The ash content was deter-
mined by placing weighed quantities of lyophilized cells
in ceramic crucibles, followed by incubation at 550°C for
6 hours. The exhaust gas leaving the fermentor was mea-
sured by LKM200A exhaust O2 and CO2 analyzer (Lokas,
Daejeon, Korea). The carbon dioxide evolution rate
(CER) and oxygen uptake rate (OUR) were deduced from
the inlet and outlet carbon dioxide and oxygen composi-
tions.
Additional material
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
BKSC performed the model reconstruction and drafted the manuscript. BKSC
and SS performed the model analysis and simulations. JR, HL(1), JA and HL(2)
performed the chemostat experiments. DYL coordinated and directed the
project, and prepared the final manuscript. All authors have read and approved
the final manuscript.
Acknowledgements
The work was supported by the Academic Research Fund (R-279-000-258-112) 
from the National University of Singapore and the Biomedical Research Coun-
cil of A*STAR (Agency for Science, Technology and Research), Singapore.
Author Details
1NUS Graduate School for Integrative Sciences and Engineering, National 
University of Singapore, 28 Medical Drive, #05-01, 117456, Singapore, 
2Bioprocessing Technology Institute, Agency for Science, Technology and 
Research (A*STAR), 20 Biopolis Way, #06-01, Centros, 138668, Singapore, 
3Biotechnology Process Engineering Center, KRIBB, Daejeon 305-806, Republic 
of Korea and 4Department of Chemical and Biomolecular Engineering, 
National University of Singapore, 4 Engineering Drive 4, 117576, Singapore
References
1. Durocher Y, Butler M: Expression systems for therapeutic glycoprotein 
production.  Curr Opin Biotechnol 2009, 20:700-707.
2. Hamilton SR, Gerngross TU: Glycosylation engineering in yeast: the 
advent of fully humanized yeast.  Curr Opin Biotechnol 2007, 18:387-392.
3. Chiba Y, Akeboshi H: Glycan engineering and production of 
'humanized' glycoprotein in yeast cells.  Biol Pharm Bull 2009, 
32:786-795.
4. Gerngross TU: Advances in the production of human therapeutic 
proteins in yeasts and filamentous fungi.  Nat Biotechnol 2004, 
22:1409-1414.
5. Walsh G: Biopharmaceutical benchmarks 2006.  Nat Biotechnol 2006, 
24:769-776.
6. Stratton J, Chiruvolu V, Meagher M: High cell-density fermentation.  
Methods in Molecular Biology 1998, 103:107-120.
7. Cregg JM: Introduction: distinctions between Pichia pastoris and other 
expression systems.  Methods Mol Biol 2007, 389:1-10.
8. Faber KN, Harder W, Ab G, Veenhuis M: Review: methylotrophic yeasts as 
factories for the production of foreign proteins.  Yeast 1995, 
11:1331-1344.
9. Cregg JM, Vedvick TS, Raschke WC: Recent advances in the expression of 
foreign genes in Pichia pastoris.  Nature Biotechnology 1993, 11:905-910.
10. Macauley-Patrick S, Fazenda ML, McNeil B, Harvey LM: Heterologous 
protein production using the Pichia pastoris expression system.  Yeast 
2005, 22:249-270.
11. Martinet W, Maras M, Saelens X, Jou WM, Contreras R: Modification of the 
protein glycosylation pathway in the methylotrophic yeast Pichia 
pastoris.  Biotechnology Letters 1998, 20:1171-1177.
12. Vassileva A, Chugh DA, Swaminathan S, Khanna N: Expression of 
hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris 
using the GAP promoter.  J Biotechnol 2001, 88:21-35.
13. Rahbarizadeh F, Rasaee MJ, Forouzandeh M, Allameh AA: Over 
expression of anti-MUC1 single-domain antibody fragments in the 
yeast Pichia pastoris.  Mol Immunol 2006, 43:426-435.
14. Yao XQ, Zhao HL, Xue C, Zhang W, Xiong XH, Wang ZW, Li XY, Liu ZM: 
Degradation of HSA-AX15(R13K) when expressed in Pichia pastoris can 
be reduced via the disruption of YPS1 gene in this yeast.  J Biotechnol 
2009, 139:131-136.
15. Lee SY, Lee DY, Kim TY: Systems biotechnology for strain improvement.  
Trends Biotechnol 2005, 23:349-358.
16. Otero JM, Nielsen J: Industrial systems biology.  Biotechnol Bioeng 2010, 
105:439-460.
17. Nielsen J, Jewett MC: Impact of systems biology on metabolic 
engineering of Saccharomyces cerevisiae.  FEMS Yeast Res 2008, 
8:122-131.
18. Petranovic D, Vemuri GN: Impact of yeast systems biology on industrial 
biotechnology.  J Biotechnol 2009, 144:204-211.
19. Bro C, Regenberg B, Forster J, Nielsen J: In silico aided metabolic 
engineering of Saccharomyces cerevisiae for improved bioethanol 
production.  Metab Eng 2006, 8:102-111.
20. Hjersted JL, Henson MA, Mahadevan R: Genome-scale analysis of 
Saccharomyces cerevisiae metabolism and ethanol production in fed-
batch culture.  Biotechnol Bioeng 2007, 97:1190-1204.
Additional file 1 Excel file contains metabolic reaction, metabolite 
and gene lists.
Additional file 2 Word document contains details on the calculation 
of biomass composition, carbon balance and ATP maintenance 
requirement.
Received: 17 May 2010 Accepted: 1 July 2010 
Published: 1 July 2010
This article is available from: http://www.microbialcellfactories.com/content/9/1/50 © 2010 Chung et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Microbial Cell Factories 2010, 9:50Chung et al. Microbial Cell Factories 2010, 9:50
http://www.microbialcellfactories.com/content/9/1/50
Page 14 of 15
21. Gonzalez R, Andrews BA, Molitor J, Asenjo JA: Metabolic analysis of the 
synthesis of high levels of intracellular human SOD in Saccharomyces 
cerevisiae rhSOD 2060 411 SGA122.  Biotechnol Bioeng 2003, 82:152-169.
22. Graf A, Dragosits M, Gasser B, Mattanovich D: Yeast systems 
biotechnology for the production of heterologous proteins.  FEMS 
Yeast Res 2009, 9:335-348.
23. Feist AM, Herrgard MJ, Thiele I, Reed JL, Palsson BO: Reconstruction of 
biochemical networks in microorganisms.  Nat Rev Microbiol 2009, 
7:129-143.
24. Oberhardt MA, Palsson BO, Papin JA: Applications of genome-scale 
metabolic reconstructions.  Mol Syst Biol 2009, 5:320.
25. Feist AM, Henry CS, Reed JL, Krummenacker M, Joyce AR, Karp PD, 
Broadbelt LJ, Hatzimanikatis V, Palsson BO: A genome-scale metabolic 
reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 
ORFs and thermodynamic information.  Mol Syst Biol 2007, 3:121.
26. Selvarasu S, Karimi IA, Ghim GH, Lee DY: Genome-scale modeling and in 
silico analysis of mouse cell metabolic network.  Mol Biosyst 2010, 
6:152-161.
27. Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, Srivas R, Palsson 
BO: Global reconstruction of the human metabolic network based on 
genomic and bibliomic data.  Proc Natl Acad Sci USA 2007, 
104:1777-1782.
28. Fong SS, Palsson BO: Metabolic gene-deletion strains of Escherichia coli 
evolve to computationally predicted growth phenotypes.  Nat Genet 
2004, 36:1056-1058.
29. Lee KH, Park JH, Kim TY, Kim HU, Lee SY: Systems metabolic engineering 
of Escherichia coli for L-threonine production.  Mol Syst Biol 2007, 3:149.
30. Lee SJ, Lee DY, Kim TY, Kim BH, Lee J, Lee SY: Metabolic engineering of 
Escherichia coli for enhanced production of succinic acid, based on 
genome comparison and in silico gene knockout simulation.  Appl 
Environ Microbiol 2005, 71:7880-7887.
31. Backlund PS Jr, Chang CP, Smith RA: Identification of 2-keto-4-
methylthiobutyrate as an intermediate compound in methionine 
synthesis from 5'-methylthioadenosine.  J Biol Chem 1982, 
257:4196-4202.
32. Hartner FS, Glieder A: Regulation of methanol utilisation pathway genes 
in yeasts.  Microb Cell Fact 2006, 5:39.
33. Carnicer M, Baumann K, Toplitz I, Sanchez-Ferrando F, Mattanovich D, 
Ferrer P, Albiol J: Macromolecular and elemental composition analysis 
and extracellular metabolite balances of Pichia pastoris growing at 
different oxygen levels.  Microb Cell Fact 2009, 8:65.
34. Wriessnegger T, Leitner E, Belegratis MR, Ingolic E, Daum G: Lipid analysis 
of mitochondrial membranes from the yeast Pichia pastoris.  Biochim 
Biophys Acta 2009, 1791:166-172.
35. De Schutter K, Lin YC, Tiels P, Van Hecke A, Glinka S, Weber-Lehmann J, 
Rouze P, Van de Peer Y, Callewaert N: Genome sequence of the 
recombinant protein production host Pichia pastoris.  Nat Biotechnol 
2009, 27:561-566.
36. Förster J, Famili I, Fu P, Palsson BØ: Genome-scale reconstruction of the 
Saccharomyces cerevisiae metabolic network.  Genome Res 2003, 
13:244-253.
37. Mo ML, Palsson BO, Herrgard MJ: Connecting extracellular metabolomic 
measurements to intracellular flux states in yeast.  BMC Syst Biol 2009, 
3:37.
38. Sola A, Jouhten P, Maaheimo H, Sanchez-Ferrando F, Szyperski T, Ferrer P: 
Metabolic flux profiling of Pichia pastoris grown on glycerol/methanol 
mixtures in chemostat cultures at low and high dilution rates.  
Microbiology 2007, 153:281-290.
39. Verduyn C, Stouthamer AH, Scheffers WA, van Dijken JP: A theoretical 
evaluation of growth yields of yeasts.  Antonie Van Leeuwenhoek 1991, 
59:49-63.
40. Stuckrath I, Lange HC, Kotter P, van Gulik WM, Entian KD, Heijnen JJ: 
Characterization of null mutants of the glyoxylate cycle and 
gluconeogenic enzymes in S. cerevisiae through metabolic network 
modeling verified by chemostat cultivation.  Biotechnol Bioeng 2002, 
77:61-72.
41. Wriessnegger T, Gubitz G, Leitner E, Ingolic E, Cregg J, de la Cruz BJ, Daum 
G: Lipid composition of peroxisomes from the yeast Pichia pastoris 
grown on different carbon sources.  Biochim Biophys Acta 2007, 
1771:455-461.
42. Inan M, Meagher MM: Non-repressing carbon sources for alcohol 
oxidase (AOX1) promoter of Pichia pastoris.  J Biosci Bioeng 2001, 
92:585-589.
43. Trinh LB, Phue JN, Shiloach J: Effect of methanol feeding strategies on 
production and yield of recombinant mouse endostatin from Pichia 
pastoris.  Biotechnol Bioeng 2003, 82:438-444.
44. Sola A, Maaheimo H, Ylonen K, Ferrer P, Szyperski T: Amino acid 
biosynthesis and metabolic flux profiling of Pichia pastoris.  Eur J 
Biochem 2004, 271:2462-2470.
45. Kroutil W, Mang H, Edegger K, Faber K: Recent advances in the 
biocatalytic reduction of ketones and oxidation of sec-alcohols.  Curr 
Opin Chem Biol 2004, 8:120-126.
46. Moore JC, Pollard DJ, Kosjek B, Devine PN: Advances in the enzymatic 
reduction of ketones.  Acc Chem Res 2007, 40:1412-1419.
47. Goldberg K, Schroer K, Lutz S, Liese A: Biocatalytic ketone reduction--a 
powerful tool for the production of chiral alcohols--part I: processes 
with isolated enzymes.  Appl Microbiol Biotechnol 2007, 76:237-248.
48. Goldberg K, Schroer K, Lutz S, Liese A: Biocatalytic ketone reduction--a 
powerful tool for the production of chiral alcohols-part II: whole-cell 
reductions.  Appl Microbiol Biotechnol 2007, 76:249-255.
49. Pscheidt B, Glieder A: Yeast cell factories for fine chemical and API 
production.  Microb Cell Fact 2008, 7:25.
50. Schroer K, Peter Luef K, Stefan Hartner F, Glieder A, Pscheidt B: 
Engineering the Pichia pastoris methanol oxidation pathway for 
improved NADH regeneration during whole-cell biotransformation.  
Metab Eng 2010, 12:8-17.
51. Burgard AP, Nikolaev EV, Schilling CH, Maranas CD: Flux coupling analysis 
of genome-scale metabolic network reconstructions.  Genome Res 
2004, 14:301-312.
52. Jungo C, Schenk J, Pasquier M, Marison IW, von Stockar U: A quantitative 
analysis of the benefits of mixed feeds of sorbitol and methanol for the 
production of recombinant avidin with Pichia pastoris.  J Biotechnol 
2007, 131:57-66.
53. Celik E, Calik P, Oliver SG: Fed-batch methanol feeding strategy for 
recombinant protein production by Pichia pastoris in the presence of 
co-substrate sorbitol.  Yeast 2009, 26:473-484.
54. Celik E, Calik P, Oliver SG: Metabolic flux analysis for recombinant 
protein production by Pichia pastoris using dual carbon sources: 
Effects of methanol feeding rate.  Biotechnol Bioeng 2010, 105:317-329.
55. Wang Z, Wang Y, Zhang D, Li J, Hua Z, Du G, Chen J: Enhancement of cell 
viability and alkaline polygalacturonate lyase production by sorbitol 
co-feeding with methanol in Pichia pastoris fermentation.  Bioresour 
Technol 2010, 101:1318-1323.
56. Cereghino JL, Cregg JM: Heterologous protein expression in the 
methylotrophic yeast Pichia pastoris.  FEMS Microbiol Rev 2000, 24:45-66.
57. Takeuchi M, Kobata A: Structures and functional roles of the sugar 
chains of human erythropoietins.  Glycobiology 1991, 1:337-346.
58. Helenius A, Aebi M: Intracellular functions of N-linked glycans.  Science 
2001, 291:2364-2369.
59. Pratt MR, Bertozzi CR: Synthetic glycopeptides and glycoproteins as 
tools for biology.  Chem Soc Rev 2005, 34:58-68.
60. Shelikoff M, Sinskey AJ, Stephanopoulos G: A modeling framework for 
the study of protein glycosylation.  Biotechnol Bioeng 1996, 50:73-90.
61. Krambeck FJ, Betenbaugh MJ: A mathematical model of N-linked 
glycosylation.  Biotechnol Bioeng 2005, 92:711-728.
62. Liu G, Marathe DD, Matta KL, Neelamegham S: Systems-level modeling 
of cellular glycosylation reaction networks: O-linked glycan formation 
on natural selectin ligands.  Bioinformatics 2008, 24:2740-2747.
63. Kim PJ, Lee DY, Jeong H: Centralized modularity of N-linked 
glycosylation pathways in mammalian cells.  PLoS One 2009, 4:e7317.
64. Bielik AM, Zaia J: Historical overview of glycoanalysis.  Methods Mol Biol 
2010, 600:9-30.
65. Taylor ME, Drickamer K: Introduction to glycobiology 2nd edition. Oxford; 
New York: Oxford University Press; 2006. 
66. Sohn SB, Graf AB, Kim TY, Gasser B, Maurer M, Ferrer P, Mattanovich D, Lee 
SY: Genome-scale metabolic model of methylotrophic yeast Pichia 
pastoris and its use for in silico analysis of heterologous protein 
production.  Biotechnol J 2010.
67. Hou BK, Kim JS, Jun JH, Lee DY, Kim YW, Chae S, Roh M, In YH, Lee SY: 
BioSilico: an integrated metabolic database system.  Bioinformatics 
2004, 20:3270-3272.Chung et al. Microbial Cell Factories 2010, 9:50
http://www.microbialcellfactories.com/content/9/1/50
Page 15 of 15
68. Chang A, Scheer M, Grote A, Schomburg I, Schomburg D: BRENDA, 
AMENDA and FRENDA the enzyme information system: new content 
and tools in 2009.  Nucleic Acids Res 2009, 37:D588-592.
69. Bairoch A: The ENZYME database in 2000.  Nucleic Acids Res 2000, 
28:304-305.
70. Caspi R, Altman T, Dale JM, Dreher K, Fulcher CA, Gilham F, Kaipa P, 
Karthikeyan AS, Kothari A, Krummenacker M, et al.: The MetaCyc database 
of metabolic pathways and enzymes and the BioCyc collection of 
pathway/genome databases.  Nucleic Acids Res 2010, 38:D473-479.
71. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, 
Katayama T, Araki M, Hirakawa M: From genomics to chemical genomics: 
new developments in KEGG.  Nucleic Acids Res 2006, 34:D354-357.
72. Varma A, Boesch BW, Palsson BO: Stoichiometric interpretation of 
Escherichia coli glucose catabolism under various oxygenation rates.  
Appl Environ Microbiol 1993, 59:2465-2473.
73. Varma A, Palsson BO: Stoichiometric flux balance models quantitatively 
predict growth and metabolic by-product secretion in wild-type 
Escherichia coli W3110.  Appl Environ Microbiol 1994, 60:3724-3731.
74. Raman K, Chandra N: Flux balance analysis of biological systems: 
applications and challenges.  Brief Bioinform 2009, 10:435-449.
75. Brooke A, Kendrick D, Meeraus A, Raman R: GAMS - A user's guide.  In 
Book GAMS - A user's guide City: GAMS Development Corporation; 1998.  
Editor ed.^eds.
76. Kim PJ, Lee DY, Kim TY, Lee KH, Jeong H, Lee SY, Park S: Metabolite 
essentiality elucidates robustness of Escherichia coli metabolism.  Proc 
Natl Acad Sci USA 2007, 104:13638-13642.
77. Chung BK, Lee DY: Flux-sum analysis: a metabolite-centric approach for 
understanding the metabolic network.  BMC Syst Biol 2009, 3:117.
78. Golovlev EL, Golovleva LA: Physiology of microbial cell and metabolic 
engineering.  Microbiology 2000, 69:149-162.
79. Gurakan T, Marison IW, Von Stockar U, Gustafsson L, Gnaiger E: Proposals 
for a standardized sample handling procedure for the determination of 
elemental composition and enthalpy of combustion of biological 
material.  Thermochim Act 1990, 172:251-266.
doi: 10.1186/1475-2859-9-50
Cite this article as: Chung et al., Genome-scale metabolic reconstruction 
and in silico analysis of methylotrophic yeast Pichia pastoris for strain improve-
ment Microbial Cell Factories 2010, 9:50